Aromatic acids in urine were studied by gas chromatography and mass spectrometry in 3 premature and 7 full term healthy infants, in 2 patients with persistent hyperphenylalaninemia, and in 11 patients with phenylketonuria. Eleven aromatic acids were determined quantitatively.
Aromatic acids in urine were studied by gas chromatography and mass spectrometry in 3 premature and 7 full term healthy infants, in 2 patients with persistent hyperphenylalaninemia, and in 11 patients with phenylketonuria. Eleven aromatic acids were determined quantitatively.
On a free diet, patients with phenylketonuria excreted large amounts of phenylacetic, mandelic, phenyllactic, o-OHphenylacetic, and phenylpyruvic acids ("phenylketonuria metabolites"), whereas the two patients with persistent hyperphenylalaninemia showed only a slightly abnormal excretion of these compounds. No or only very small amounts of phenylketonuria metabolites were found in healthy infants on normal diet, as well as in patients with persistent hyperphenylalaninemia or phenylketonuria on low phenylalanine diet.
After an oral L-phenylalanine load (100 mg/kg) n o or only a slight increase of phenylketonuria metabolites was observed in the urine during the subsequent 24 h r in healthy infants o n normal diet, as well as in the two patients with persistent hyperphenylalaninemia o n low phenylalanine diet; in contrast, the concentration of these metabolites increased markedly in patients with phenylketonuria on low phenylalanine diet. This divergent response of the aromatic acids in urine to an oral phenylalanine load administered during a low phenylalanine diet probably represents a useful criterion for the differential diagnosis of these t w o conditions.
Speculation
The quantitative determination of the aromatic acids in urine before and after phenylalanine load can be considered as an indirect measurement of phenylalanine hydroxylase activity.
after birth and remains subsequently mostly between 4 and 15 mg/100 ml. On a normal protein intake, it only rarely rises t o 20 or more mg/100 ml. The urine tests for aromatic acids (FeC13, DNPH, Phenistix) are usually negative and, with few exceptions (1, 14, 28, 36) , o-OH-phenylacetic acid as well as phenylpyruvic acid are not detectable by paper chromatography (12, 17, 29, 30) or spectrophotometry (1) . However, abnormal amounts of aromatic acids can always be demonstrated after a phenylalanine load (1, 17, 24, 28, 30, 35, 36) . Most patients, whether o n or off a diet, perform within the average range of intelligence (3) .
Persistent hyperphenylalaninemia has t o be distinguished from other disorders of phenylalanine metabolism such as phenylalanine transaminase deficiency and transient hyperphenylalaninemia (see reviews in References 1 3 and 23). Patients with persistent hyperphenylalaninemia probably represent a biochemically and genetically heterogeneous group.
In the present study, aromatic acids in urine were determined quantitatively by gas chromatography and identified by mass spectrometry. The investigation was performed in healthy infants, as well as in patients with persistent hyperphenylalaninemia and phenylketonuria, before and after a phenylalanine load. The patients were studied while on and off a low phenylalanine diet.
SUBJECTS AND METHODS
Aromatic acid excretion in urine was studied in 3 healthy premature infants, aged 2-5.5 weeks (weight at birth 1,580-2,180 g; at examination 2,990-2,500 g), in healthy full term infants, aged 1-9 months (weight 3,320-9,300 g), in 2 patients with persistent hyperphenylalaninemia, aged 2-4 months, and in 11 patients with phenylketonuria, aged 11 days-1 1.75 years. For better comparison, the healthy subjects were chosen from the same age group as the two patients with persistent hyperphenylalaninemia. These two cases are as In phenylketonuria there is n o demonstrable activity of follows.
hepatic phenylalanine hydroxylase (9, 15) , t h e enzyme which CASE LA converts phenylalanine t o tyrosine. Phenylalanine is metabolized b y alternate minor pathways and significant amounts of A girl, birth weight 3,270 g, first-born of healthy Italian several unusual but not abnormal metabolites are formed and parents, had no family history of phenylketonuria, mental excreted in urine (see reviews in References 2 0 and 27).
retardation, o r consanguinity. She was breast fed, and the
In persistent hyperphenylalaninemia (1 -4, 6-7, 11 -14, 17 , Guthrie test at 6 , 10, and 1 3 days was 5-6 mg/100 ml 21 -24, 28-3 1, 35, 36) , the activity of the phenylalanine phenylalanine. At 18 days she was placed on a cow's milk hydroxylase seems to be decreased but not totally absent, as preparation (protein 4.9 g/kg/24 hr); a t 2 4 days t h e Guthrie demonstrated by enzyme assays in a few studies (16, 17, 19 , test showed a level of phenylalanine in blood of about 2 0 30). The level of phenylalanine in plasma rises rather slowly mg/100 ml, and column chromatography a concentration of 11 mg/100 m l at 2 7 days and of 19.7 mg/100 ml at 29 days. She was then started on a low phenylalanine diet; the level of phenylalanine in plasma fell t o 1.46 mg/100 ml within 2 days. The phenylalanine intake with the diet was increased gradually t o 100 mg/kg/24 hr and the level of phenylalanine in plasma remained between 3.96 and 11.87 mg/100 ml (column chromatography). From the age of 3.75 months, she was given a free diet and the mean level of phenylalanine in plasma did not increase; however, occasional peaks occurred, especially with infections. The FeC13, DNPH, and Phenistix tests were persistently negative, EEGs at 1 month and a t 3.5 years were normal. Height and weight within the low normal range. DQ was 9 2 a t 5.5 months and 100 at 7.5 months; IQ was 102 at 3.5 years.
CASE S R
This child, a boy, birth weight 3,300 g, was the first child of unrelated Swiss parents; there was no family history of phenylketonuria or mental retardation. With breast feeding, t h e level of phenylalanine in plasma was about 5 mg/100 ml; at 3 months, after I month of feeding with a protein-rich cow's milk preparation, the phenylalanine concentration rose t o 19.6 mg/100 ml. After a period o n a low phenylalanine diet, the phenylalanine intake was gradually increased t o 100 mg/kg/24 hr and the level of phenylalanine in plasma from 3.77 t o 6.43 mg/100 ml. At 3.75 months he was placed on a free diet, and the level of phenylalanine in plasma generally remained between 3.38 and 8.17 mg/100 ml with occasional peaks t o 13.13 mg/100 ml (column chromatography). At 8 months, t h e child was started on a low protein diet (2.1 g/kg/24 hr), which was later completed with a phenylalaninefree mixture. The FeCI3, DNPH, and Phenistix test were always negative. EEGs at 4 and 5.5 months were normal. Height and weight were normal. DQ was 8 2 at 5.5 months and 104 at 8.5 months; IQ was 105 at 3 years 7 months.
L-Phenylalanine (100 mg/kg body wt) was administered in water o r in a 111 mixture of water and orange juice, 200 ml/m2 after an overnight fast. The phenylalanine load was performed in healthy infants (9 of the 10 subjects) while on a normal diet, and in the 2 patients with persistent hyperphenylalaninemia while on a low phenylalanine and on a free diet. Two patients with phenylketonuria were investigated when o n and off the diet; five were o n diet only, and the remaining four were on a free diet.
The level of phenylalanine in plasma was determined by column chromatography with a short program, as described previously (25) .
Aromatic acids were determined in the urine samples of 2 4 h r before, and in those of the first 4 hr and the subsequent 2 0 hr after load, using the method published previously (32) except for the following: 15 ml instead of 10 ml ethyl acetate was used three times for the extraction. The silylation was carried out for 15 min with 0.1 ml bis(trimethylsily1)trifluoroacetamide at room temperature. Gas chromatography was performed with glass columns XE 60 3% on Gaschrom Q 80-100 mesh (2 m by 2.7 m m inner diameter), using a temperature grogram of 2'/min, 90-220'; injector, 250'; detector, 230 .
When o-hydroxyphenylacetic acid was added t o urine before extraction, the recovery in 10 separate determinations was about 80%. T o overcome losses during the extraction procedure, the calibration curves were established by analyzing the test mixture by the procedure mentioned above. The variation coefficient of 10 determinations in the same urine was 8.2%.
RESULTS

PHENYLALANINE CONCENTRATIONS IN PLASMA
Phenylalanine concentrations (mean and s) before and after load of the children with phenylketonuria and of the two patients with persistent hyperphenylalaninemia are shown in Tables 1 and 2 . The values before and 1, 2, 3, and 4 hr after loading, as well as the difference between the postloading concentrations of the first 4 hr and the zero time values of the two groups on diet are not significantly different (P > 0.1).
Only the corresponding values 2 4 hr after loading are higher in the patients with phenylketonuria (0.01 < P < 0.05).
AROMATIC ACIDS IN URINE
Aromatic acids which could be demonstrated with this method and their concentration (micrograms per milligram of creatinine) in urine of the three groups of subjects studied are shown in Tables 3-6 . The sensitivity of the method used allows t o calculate amounts as small as 1 pg/mg creatinine; smaller but clearly detectable quantities are listed in the tables as <1 pg/mg creatinine. For the calculation of mean and standard deviation, values <1 were assumed t o be 0.5 pg/mg creatinine. The range of the individual values was rather large, but there was no relation between the concentration of the aromatic acids in urine (pg/mg creatinine) and the age of the patients. Phenylalanine in plasma (milligrams per 100 ml; mean and s) in six patients with phenylketonuria and two with persistent hyperphenylalaninemia. nd: not detectable.
The amount of excretion of the aromatic acids was expressed in micrograms per milligram of creatinine because the subjects were of different ages and consequently the data of the total excretion per 24 hr would not be sufficiently representative.
Hippuric acid was also present in all subjects, but the quantity was not calculated. Some results (individual values of the patients with phenylketonuria on free diet before phenylalanine load and of the healthy infants before load) have already been published in a communication concerning methodology (32) .
According t o their behavior, the aromatic acids demonstrated with this method can be subdivided into three groups.
Group I: Phenylketonuria Metabolites. In untreated phenylketonuria, as shown in Table 3 , phenylacetic, mandelic, phenyllactic, o-OH-phenylacetic, and phenylpyruvic acids are excreted in large amounts. The urine concentration of these compounds showed no relation t o the age of the patients. These five aromatic acids will hence be called phenylketonuria metabolites; their level of excretion was different in the three groups of subjects investigated.
Group l a : Healthy Infants (Table 4) . No or only small amounts of phenylketonuria metabolites were excreted by these children before a phenylalanine load, and no or only a slight increase was observed after load. There was n o difference between premature and full term infants.
Group Ib: Patients with Persistent Hyperphenylalaninemia (Table 5 ). An excretion pattern similar to that in healthy infants was found in these children while they were on low phenylalanine diet (before and after phenylalanine load); however, on free diet, some phenylketonuria metabolites were excreted in slightly abnormal amount before the load and there was a marked increase after the load.
Group Ic: Patients with Phenylketonuria. On low phenylalanine diet (Table 6 ), as expected, n o or only small amounts of phenylketonuria metabolites were excreted before the load; however, in contrast t o the findings in patients with persistent hyperphenylalaninemia, the concentration of these metabolites increased strongly after load. On the free diet ( Table 3) the excretion was high before load and increased further after the load.
Group 11: p-OH-Phenyllactic Acid and p-OH-Phenylpyruvic
Acid. The mean excretion of these two aromatic acids was significantly higher in children with phenylketonuria on a free diet than in healthy full term infants. These substances are not phenylalanine metabolites; their abnormal excretion in phenylketonuria is probably caused by a secondary inhibition of metabolic pathways of tyrosine b y some phenylalanine metabolites, what has also been recently studied by administration of deuterated phenylalanine (8) .
Two healthy premature infants showed a level of excretion of p-OH-phenyllactic acid and p-OH-phenylpyruvic acid similar t o that of the children with phenylketonuria. Furthermore, there was an increase of these metabolites in urine after a phenylalanine load in some but not all patients with phenylketonuria while they were on a free diet, but not while they were on a low phenylalanine diet, and there was a very slight increase in the two children with persistent hyperphenylalaninemia while they were on a free diet. For these reasons, p-OH-phenyllactic acid and p-OH-phenylpyruvic acid were not included in the group of the phenylketonuria metabolites for the purposes of this report.
Group 1111: Other Metabolites. The excretion of the other aromatic acids showed n o difference in the three groups of subjects studied, either before or after phenylalanine loading. No values are presented for m-OH-phenylacetic acid, as the mass spectrometric analysis revealed that the corresponding peak was not only a signal of this, but also of another unknown compound.
Other phenylketonuria metabolites, such as phenylacetylglutamine, are not detectable with the method employed. The reported values for phenylacetic acid d o not include phenylacetic acid other than phenylacetylglutamine. (5), and Wadman e t al. (33) .
Our findings in this disease (Table 3) confirm the results obtained by previous authors with other techniques, mainly paper chromatography (see review in References 20 and 27), i.e., an abnormally high level of excretion of phenylacetic, phenyllactic, o-OH-phenylacetic, and phenylpyruvic acid. Like Blau (5) and Wadman e t al. (33) , who also used gas chromatography, we found a constantly abnormal excretion of mandelic acid. This compound must therefore be considered as a further characteristic metabolite in phenylketonuria (phenylketonuria metabolites).
Healthy infants on a normal diet (Table 4) , as well as patients with persistent hyperphenylalaninemia (Table 5) or phenylketonuria (Table 6 , References 5 and 33) on a low phenylalanine diet excrete n o or only very small amounts of these substances. A marked difference between the patients with persistent hyperphenylalaninemia and those with phenylketonuria can be observed while these children are on a free diet; in fact the former excrete only relatively small amounts of phenylketonuria metabolites (Table 5) . Furthermore, Blau (5) found a normal aromatic acid excretion in three patients with hyperphenylalaninemia because the increased level of phenylalanine in plasma in persistent hyperphenylalaninernia is in general moderate and insufficient t o cause significant overproduction of unusual metabolites.
AROMATIC ACIDS EXCRETION AFTER PHENYLALANINE LOAD
In urine collected after a phenylalanine load, different excretion patterns could be found in healthy infants, the two patients with persistent hyperphenylalaninemia, and the children with phenylketonuria (Tables 3-6 ). The results in these three groups of subjects are summarized in Table 7 . With respect t o the differential diagnosis between persistent hyperphenylalaninemia and phenylketonuria, the findings for a low phenylalanine diet are of particular interest. In both diseases, n o or only very small amounts of phenylketonuria metabolites are excreted before a phenylalanine load; after the load, a high increase of these aromatic acids takes place in phenylketonuria, whereas in persistent hyperphenylalaninemia, no significant change occurs (Tables 5 and 6 ). The quantitative determination of aromatic acids in urine may be considered t o be an indirect measurement of the phenylalanine hydroxylase activity (Table 7) . If this enzyme system is normal, as in healthy infants, the loading dose of 100 mg phenylalaninelkg body wt will be metabolized without formation of phenylketonuria metabolites. In heterozygotes for phenylketonuria, we found, after a load, a slightly higher mean excretion of o-OH-phenylacetic acid than in normal subjects, but there was an overlap of several values of the two groups (26) .
In persistent hyperphenylalaninemia the phenylalanine hydroxylase activity is decreased markedly but is not totally absent (16, 17, 19, 30) . The remaining enzyme activity is nearly sufficient t o metabolize the phenylalanine contained in a normal diet. The two patients with persistent hyperphenylalaninemia are able t o metabolize a loading phenylalanine dose also, when they are o n low phenylalanine diet, but not when they are on a free diet. In this last condition of testing, phenylketonuria metabolites are excreted in significant amounts; the aromatic acids excretion pattern is identical with that in phenylketonuria. Giittler and Wamberg ( I I ) also found a high excretion of o-OH-phenylacetic acid (photometric Table 5 . Aromatic acids in urine in two patients with persistent hyperphenylalaninernia before and after phenylalanine load1 method) in three patients with persistent hyperphenylalaninemia after a load performed on a free diet.
In phenylketonuria, there is no demonstrable phenylalanine hydroxylase activity; unusual metabolites will be excreted in each instance in which this enzyme system is necessary to metabolize phenylalanine, i.e., on a free diet (before and after loading) as well as after loading when the patients are o n a low phenylalanine diet.
It should be pointed out that determination of aromatic acids in urine may be considered as an indirect measurement of the phenylalanine hydroxylase activity only if the metabolic defect in t h e subjects investigated is limited to this enzymatic system; we have n o biochemical reasons t o assume the presence of additional metabolic defects in our patients.
The analysis of aromatic acids in urine before and after load appears t o represent a useful criterion t o distinguish persistent hyperphenylalaninetnia from phenylketonuria. However, as we had the opportunity t o study only two patients with persistent hyperphenylalaninernia and because patients with this disorder probably constitute a heterogeneous group, conclusions from this investigation may be extended to all cases of persistent hyperphenylalaninernia with caution only. In spite of t h e similar values for phenylalanine in plasma during the first 4 hr after load, the aromatic acids excretion within this time was markedly different in the two groups (Tables 5 and 6 ). Although the data of the present investigation d o not offer a clear explanation of this fact, some possible mechanisms are discussed briefly.
The low phenylalanine hydroxylase activity present in the patients with persistent hyperphenylalaninernia is not or only scarcely utilized for the metabolism of the phenylalanine contained in a strong controlled diet. It is conceivable that this still available enzymatic activity allows a gradual conversion of the loading phenylalanine t o tyrosine; this could explain the absence of phenylalanine metabolites in urine after a load which is performed on a diet. The high tolerance for the phenylalanine of an unrestricted diet of these children was also explained by this mechanism (1 I). Another possibility could be the presence in hyperphenylalaninemics of a mechanism for the elimination of phenylalanine different from that in patients with phenylketonuria. Lines and Waisman (22) found that the excretion of phenylalanine in urine (milligrams per gram of creatinine) of patients with hyperphenylalaninemia was not statistically different from that of children with phenylketonuria off diet, although the level phenylalanine in plasma was reduced b y half. This fact prompted the hypothesis that patients with hyperphenylalaninemia could be protected b y a high level of excretion of phenylalanine. On the other hand, Giittler and Rosleff (10) showed that the amount of phenylalanine in urine after a load was lower in five children with persistent hyperphenylalaninemia off diet than in eight children with phenylketonuria on diet, in spite of similar values for phenylalanine in plasma 1 hr after loading. We have not determined t h e level of excretion of phenylalanine in urine in our patients.
Until now, n o data support the hypothesis that another metabolic pathway for phenylalanine degradation may exist in patients with persistent hyperphenylalaninernia or that the phenylketonuria metabolites are unusually quickly metabolized in these patients.
SUMMARY
The aromatic acids in urine were studied by gas chromatography and mass spectrometry in 10 healthy infants, 2 patients with persistent hyperphenylalaninemia, and 11 patients with phenylketonuria. The investigations were performed before and after a phenylalanine load, and in the patients while they were on and off a low phenylalanine diet. Eleven aromatic acids were determined quantitatively.
On a free diet, a highly abnormal level of excretion of phenylacetic, mandelic, phenyllactic, o-OH-phenylacetic, and phenylpyruvic acids was found in phenylketonuria (phenylketonuria metabolites), whereas patients with persistent hyperphenylalaninemia excreted only slightly abnormal amounts of these compounds. The main difference between these two conditions was observed after the phenylalanine load, when the patients were given a low phenylalanine diet. In both diseases, no o r only very small amounts of phenylketonuria metabolites were excreted before phenylalanine loading; after loading, a marked increase of these metabolites in urine was observed in phenylketonuria, while no significant change occurred in persistent hyperphenylalaninernia. The difference in behavior could be used as a differential diagnostic criterion between t h e two diseases.
